Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
18.20
-0.80 (-4.21%)
At close: Jun 18, 2026, 4:00 PM EDT
15.40
-2.80 (-15.38%)
After-hours: Jun 18, 2026, 7:57 PM EDT
Akanda Revenue
In the year 2025, Akanda had annual revenue of $258.08K, down -69.15%.
Revenue (ttm)
$258.08K
Revenue Growth
-69.15%
P/S Ratio
55.41
Revenue / Employee
$5,610
Employees
46
Market Cap
14.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 258.08K | -578.59K | -69.15% |
| Dec 31, 2024 | 836.66K | 412.98K | 97.47% |
| Dec 31, 2023 | 423.68K | -2.20M | -83.83% |
| Dec 31, 2022 | 2.62M | 2.58M | 6,223.00% |
| Dec 31, 2021 | 41.43K | 39.37K | 1,909.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| cbdMD | 19.98M |
| InMed Pharmaceuticals | 4.94M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
| Gelteq | 270.85K |
AKAN News
- 13 hours ago - Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement - Newsfile Corp
- 6 days ago - Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement - Newsfile Corp
- 27 days ago - Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter - Newsfile Corp
- 27 days ago - Akanda Corp. Announces Cancellation of Special Meeting - Newsfile Corp
- 4 weeks ago - Akanda Corp trading resumes - TheFly
- 4 weeks ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 6 weeks ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 6 weeks ago - Akanda Corp trading resumes - TheFly